Search

A case report from Nippon Medical School Hospital in Tokyo, Japan, discusses a female patient with vascular Ehlers-Danlos syndrome (vEDS) who developed pulmonary Mycobacterium avium complex (MAC) infection. The patient also had multiple intestinal perforations and bilateral external iliac artery dissection. Treatment with rifampicin, ethambutol, and clarithromycin improved respiratory symptoms and resulted in negative acid-fast bacilli cultures. This case highlights the rare complications associated with vEDS and suggests a possible mechanism of infection. Further research is needed on respiratory infections in patients with vEDS and MAC disease. [Extracted from the article]

A study conducted at the Cleveland Clinic in Ohio examined the outcomes of lung transplant recipients with pre-transplant Mycobacterium avium complex (MAC) infection. The researchers found that out of 882 patients who received lung transplants between 2013 and 2020, 14 patients (2%) met the criteria for MAC pulmonary disease (MAC-PD). Seven of these patients had MAC-PD before the transplant, and none of the patients developed MAC-PD after the transplant. The study suggests that pre- or post-transplant MAC treatment may not be necessary for smear-negative patients who undergo bilateral lung transplants. [Extracted from the article]

Researchers from the University of Toledo College of Medicine and Life Sciences have published a case report on disseminated Mycobacterium avium complex (MAC) spinal osteomyelitis in a patient with interferon gamma receptor deficiency. Disseminated MAC infection is rare and typically occurs in immunodeficient individuals, with the majority of cases being associated with HIV. This case highlights the occurrence of MAC vertebral osteomyelitis in a patient with interferon gamma receptor deficiency, which is mechanistically linked to mycobacterial infection. Further information on this research can be found in the Radiology Case Reports journal. [Extracted from the article]

Insmed Incorporated has been issued a patent for methods of treating pulmonary non-tuberculous mycobacterial (NTM) infections. The patent describes the use of liposomal complexed aminoglycosides administered via inhalation to provide a prolonged therapeutic effect and enhanced drug uptake in the lungs. Pulmonary NTM infections, particularly caused by Mycobacterium avium complex (MAC), are a growing public health concern in the United States. The methods described in the patent aim to address the need for effective treatments for patients with pulmonary NTM infections, including those with underlying lung diseases such as cystic fibrosis, bronchiectasis, asthma, or chronic obstructive pulmonary disorder (COPD). [Extracted from the article]

A recent study conducted in Hebei, People's Republic of China, focused on non-tuberculous mycobacterial pulmonary infections (NTM-PD), which are becoming more common in clinical practice. The study aimed to determine the infecting pathogen in order to facilitate appropriate treatment. The researchers reported a case of NTM-PD in a healthy middle-aged female with Mycobacterium tuberculosis complex group (MAC) infection confirmed by mNGS examination. The study concluded that early detection and accurate determination of pathogens in pulmonary infections is crucial, and that mNGS of bronchoscopic alveolar lavage fluid (BALF) samples has high specificity in detecting infectious disease pathogens. [Extracted from the article]

A recent study conducted by researchers at Portland State University examined the tolerability outcomes of multidrug antibiotic regimens used to treat Mycobacterium avium complex pulmonary disease (MAC-PD) in Medicare beneficiaries with bronchiectasis. The study found that clarithromycin-based regimens were more likely to be changed or discontinued within 12 months of therapy initiation compared to azithromycin-based regimens. Additionally, rifabutin-containing regimens were more likely to be changed or discontinued compared to rifampin-containing regimens. Overall, the study provides valuable insights into the tolerability of antibiotic treatments for MAC-PD. [Extracted from the article]

A new report from researchers in Madrid, Spain discusses the biofilm prevention concentration of clarithromycin against clinically relevant species of nontuberculous mycobacteria (NTM), specifically Mycobacterium avium complex (MAC) and Mycobacterium abscessus. The ability of these bacteria to develop biofilms in tissues and medical devices is an important factor in their pathogenicity. The study found that macrolides, such as clarithromycin, could potentially be used to prevent biofilm development in patients at risk of developing NTM disease. The research was funded by the Spanish Government, European Union, and Libyan Government, and has been peer-reviewed. [Extracted from the article]

A patent application has been filed for compositions and methods to treat non-tuberculous mycobacterial (NTM) infections. NTM infections are becoming more common and are linked to lung infections in patients with lung diseases. The current treatments have low success rates and side effects, so alternative approaches are needed. The patent application proposes a composition containing anti-malarial agents and a carrier to treat NTM infections and alleviate symptoms. The composition may also include antibiotics. The application describes the methods of administering the composition and mentions potential benefits such as enhancing biological processes and reducing biofilm formation. [Extracted from the article]

Researchers from the National Institute of Infectious Diseases in Tokyo, Japan have conducted a comprehensive analysis of the transcriptome of macrophages infected with Mycobacterium avium complex (MAC). MAC is a non-tuberculous mycobacterium that is widely distributed in the environment and is increasing in prevalence among older women and immunocompromised patients. The study found that MAC infection induced the expression of immune/inflammatory response genes and other genes associated with macrophage activation. The researchers also identified differentially expressed long non-coding RNAs (lncRNAs) that play distinct roles in MAC infection and macrophage polarization. The study suggests that toll-like receptor 2 is involved in the expressional changes of lncRNAs in MAC-infected macrophages. [Extracted from the article]

A study conducted at Queen's University in Belfast, United Kingdom, has found that human mesenchymal stromal cells (MSCs) can inhibit the growth of Mycobacterium avium complex (MAC) bacteria in lung infections. The researchers investigated the effects of MSCs on MAC-infected macrophages and in a murine model of MAC pulmonary disease. They found that MSCs reduced intracellular bacteria in macrophages and inhibited pulmonary bacterial replication in mice. The study suggests that MSCs have potential as a novel therapeutic strategy for MAC pulmonary disease. [Extracted from the article]

Researchers from Stanford University School of Medicine have conducted a study on Mycobacterium avium complex (MAC) pulmonary disease. The study aimed to identify variables associated with adverse drug reactions (ADR) in patients undergoing antibiotic treatment for MAC. The retrospective study analyzed the treatment courses of 246 patients and found that 43% experienced ADRs. Factors associated with ADRs included smear positive sputum cultures, a higher Charlson Comorbidity Index, and existing liver disease. The study suggests the need for a systematic approach to addressing ADRs in MAC treatment. [Extracted from the article]

A recent study conducted by researchers from the National Institute of Allergy and Infectious Diseases (NIAID) focused on the prevalence of nontuberculous mycobacteria (NTM) infections in the United States. NTM are environmental bacteria that can cause chronic lung disease, and their prevalence has been increasing globally. The study analyzed data from Laboratory Corporation of America (Labcorp) for respiratory samples sent for testing from January 2019 to mid-April 2022. The results showed that the Southeastern region of the U.S. had the highest rate of culture positivity for NTM, particularly Mycobacterium abscessus. However, the study acknowledged that these estimates may not capture the true number of M. abscessus infections due to limitations in testing methods. The researchers suggested that analyzing real-time testing data from commercial laboratories could provide valuable insights into risk factors for NTM infections in hotspot areas. [Extracted from the article]

A recent study conducted by researchers at Far Eastern Memorial Hospital examined the treatment regimens and duration for patients with Mycobacterium avium complex lung disease (MAC-LD). The study found that guideline-based therapy (GBT) is the preferred treatment, but it is not always feasible. The researchers analyzed the outcomes of 106 patients with MAC-LD and found that triple therapy (three active drugs) and treatment duration of more than 12 months resulted in higher proportions of favorable outcomes. The study suggests that maintaining triple therapy and extending treatment duration may be acceptable alternatives to GBT. [Extracted from the article]

Researchers at the University of Texas at Tyler have conducted a study on the pharmacokinetics/pharmacodynamics (PK/PD) of sarecycline in treating Mycobacterium avium complex pulmonary disease (MAC-PD). The study found that sarecycline demonstrated anti-MAC effects in a hollow-fibre system model, but achieving the optimal exposure of sarecycline in patients may be challenging. The research highlights the need for better drugs to treat MAC-PD. This information may be useful for library patrons researching treatments for MAC-PD. [Extracted from the article]

Researchers at the University of Bologna have published a report on the isolation of Mycobacterium saskatchewanense from medical devices. This species of pigmented slow-growing Non-Tuberculous Mycobacteria (NTM) is positive for Mycobacterium avium complex (MAC). The study emphasizes the importance of correctly identifying NTMs that often colonize sanitary water in medical devices. The researchers used various methods, including GenoType Mycobacterium CM CE-IVD kit and Next Generation Sequencing, to confirm the identification of M. saskatchewanense. The findings highlight the need for active monitoring of NTM contamination in medical devices to prevent patient infections. [Extracted from the article]

Actinobacteria, Actinomycetales, Atypical Mycobacteria, Diagnostics and Screening, Gram-Positive Asporogenous Rods, Gram-Positive Bacteria, Gram-Positive Rods, Health and Medicine, Mycobacteria, Mycobacteriaceae, Mycobacterium, Mycobacterium avium, Mycobacterium avium Complex, Risk and Prevention Keywords: Actinobacteria; Actinomycetales; Atypical Mycobacteria; Diagnostics and Screening; Gram-Positive Asporogenous Rods; Gram-Positive Bacteria; Gram-Positive Rods; Health and Medicine; Mycobacteria; Mycobacteriaceae; Mycobacterium; Mycobacterium avium; Mycobacterium avium Complex; Risk and Prevention EN Actinobacteria Actinomycetales Atypical Mycobacteria Diagnostics and Screening Gram-Positive Asporogenous Rods Gram-Positive Bacteria Gram-Positive Rods Health and Medicine Mycobacteria Mycobacteriaceae Mycobacterium Mycobacterium avium Mycobacterium avium Complex Risk and Prevention 1567 1567 1 10/30/23 20231103 NES 231103 2023 NOV 3 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on Mycobacterium avium complex is now available. [Extracted from the article]

Keywords: Actinobacteria; Actinomycetales; Atypical Mycobacteria; Clinical Research; Clinical Trials and Studies; Drugs and Therapies; Gram-Positive Asporogenous Rods; Gram-Positive Bacteria; Gram-Positive Rods; Health and Medicine; Hospitals; Lung Diseases and Conditions; Mycobacteria; Mycobacteriaceae; Mycobacterium; Mycobacterium avium; Mycobacterium avium Complex; Respiratory Tract Diseases and Conditions EN Actinobacteria Actinomycetales Atypical Mycobacteria Clinical Research Clinical Trials and Studies Drugs and Therapies Gram-Positive Asporogenous Rods Gram-Positive Bacteria Gram-Positive Rods Health and Medicine Hospitals Lung Diseases and Conditions Mycobacteria Mycobacteriaceae Mycobacterium Mycobacterium avium Mycobacterium avium Complex Respiratory Tract Diseases and Conditions 2118 2118 1 10/16/23 20231020 NES 231020 2023 OCT 16 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- New study results on lung diseases and conditions have been published. Therapeutic drug monitoring has the potential to improve treatment outcome by ensuring adequate drug exposure. [Extracted from the article]

Keywords: Actinobacteria; Actinomycetales; Antibacterials; Antibiotics; Antimicrobials; Drugs and Therapies; Gram-Positive Asporogenous Rods; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Gram-Positive Rods; Health and Medicine; Mycobacteria; Mycobacteriaceae; Mycobacterium; Mycobacterium Avium Complex; Mycobacterium avium EN Actinobacteria Actinomycetales Antibacterials Antibiotics Antimicrobials Drugs and Therapies Gram-Positive Asporogenous Rods Gram-Positive Bacteria Gram-Positive Bacterial Infections Gram-Positive Rods Health and Medicine Mycobacteria Mycobacteriaceae Mycobacterium Mycobacterium Avium Complex Mycobacterium avium 1907 1907 1 10/09/23 20231009 NES 231009 2023 OCT 9 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Data detailed on mycobacterium avium complex have been presented. All selected drug combinations showed synergistic activity, reducing BBC values compared to those treated with single drugs, but BBC values remained high enough to treat patients. [Extracted from the article]

To identify the Mycobacterium genus, M. tuberculosis and MAC, it was amplified a fragment of hsp65 gene, esat-6 gene, and the internal transcribed spacer between the 16S and 23S rRNA genes, respectively. Rio Grande, Brazil, South America, Actinobacteria, Actinomycetales, Diagnostics and Screening, Genetics, Gram-Positive Asporogenous Rods, Gram-Positive Bacteria, Gram-Positive Bacterial Infections, Gram-Positive Rods, Health and Medicine, Multiplex PCR, Mycobacteria, Mycobacteriaceae, Mycobacterium, Mycobacterium Avium Complex, Atypical Mycobacteria, Mycobacterium Infections, Mycobacterium Tuberculosis, Mycobacterium avium, Mycobacterium avium Complex, Mycobacterium tuberculosis, Tuberculosis Keywords: Rio Grande; Brazil; South America; Actinobacteria; Actinomycetales; Atypical Mycobacteria; Diagnostics and Screening; Genetics; Gram-Positive Asporogenous Rods; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Gram-Positive Rods; Health and Medicine; Multiplex PCR; Mycobacteria; Mycobacteriaceae; Mycobacterium; Mycobacterium Avium Complex; Mycobacterium Infections; Mycobacterium Tuberculosis; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium tuberculosis; Tuberculosis EN Rio Grande Brazil South America Actinobacteria Actinomycetales Atypical Mycobacteria Diagnostics and Screening Genetics Gram-Positive Asporogenous Rods Gram-Positive Bacteria Gram-Positive Bacterial Infections Gram-Positive Rods Health and Medicine Multiplex PCR Mycobacteria Mycobacteriaceae Mycobacterium Mycobacterium Avium Complex Mycobacterium Infections Mycobacterium Tuberculosis Mycobacterium avium Mycobacterium avium Complex Mycobacterium tuberculosis Tuberculosis 604 604 1 09/11/23 20230912 NES 230912 2023 SEP 15 (NewsRx) -- By a News Reporter-Staff News Editor at TB & Outbreaks Week -- Investigators discuss new findings in Gram-Positive Bacteria - Mycobacterium avium Complex. [Extracted from the article]

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. Keywords: Allergies; Cystic Fibrosis; Digestive System Diseases and Conditions; Epidemiology; Government Agencies Offices and Entities; Gram-Positive Bacterial Infections; Health and Medicine; Immune System Diseases and Conditions; Infectious Diseases and Conditions; Lung Diseases and Conditions; Mycobacterium Avium Complex; NIH/National Institute of Allergy and Infectious Diseases; Pancreatic Diseases and Conditions; Respiratory Tract Diseases and Conditions EN Allergies Cystic Fibrosis Digestive System Diseases and Conditions Epidemiology Government Agencies Offices and Entities Gram-Positive Bacterial Infections Health and Medicine Immune System Diseases and Conditions Infectious Diseases and Conditions Lung Diseases and Conditions Mycobacterium Avium Complex NIH/National Institute of Allergy and Infectious Diseases Pancreatic Diseases and Conditions Respiratory Tract Diseases and Conditions 391 391 1 09/11/23 20230911 NES 230911 2023 SEP 11 (NewsRx) -- By a News Reporter-Staff News Editor at Gastroenterology Week -- WHAT: High levels of some minerals and metals in environmental water supplies may increase the risk of nontuberculous mycobacteria (NTM) pulmonary infections in people with cystic fibrosis, according to a new study from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. [Extracted from the article]

Actinobacteria, Actinomycetales, Atypical Mycobacteria, Gram-Positive Asporogenous Rods, Gram-Positive Bacteria, Gram-Positive Bacterial Infections, Gram-Positive Rods, Health and Medicine, Mycobacteria, Mycobacteriaceae, Mycobacterium, Mycobacterium Avium Complex, Mycobacterium avium, Mycobacterium avium Complex Keywords: Actinobacteria; Actinomycetales; Atypical Mycobacteria; Gram-Positive Asporogenous Rods; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Gram-Positive Rods; Health and Medicine; Mycobacteria; Mycobacteriaceae; Mycobacterium; Mycobacterium Avium Complex; Mycobacterium avium; Mycobacterium avium Complex EN Actinobacteria Actinomycetales Atypical Mycobacteria Gram-Positive Asporogenous Rods Gram-Positive Bacteria Gram-Positive Bacterial Infections Gram-Positive Rods Health and Medicine Mycobacteria Mycobacteriaceae Mycobacterium Mycobacterium Avium Complex Mycobacterium avium Mycobacterium avium Complex 4997 4997 1 08/21/23 20230825 NES 230825 2023 AUG 25 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New research on Mycobacterium avium complex is the subject of a new report. [Extracted from the article]

2020 JUL 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on lung diseases and conditions have been published. According [...]

Following recent data from an ongoing supportive non-clinical program, RedHill plans to initiate a single, pivotal Phase 3 study evaluating RHB-204 as a first-line, stand-alone treatment for pulmonary NTM infections [...]

2020 MAY 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Gram-Positive Bacteria - Mycobacterium avium Complex have been presented. [...]

2020 APR 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Respiratory Tract Diseases and Conditions - Lung Diseases [...]

Insmed announced that it has submitted a new drug application to Japan's Ministry of Health, Labour and Welfare for ARIKAYCE for the treatment of patients with non-tuberculous mycobacterial lung disease [...]

Keywords: Actinobacteria; Actinomycetales; Atypical Mycobacteria; Bronchoscopy; Diagnostics and Screening; Gram-Positive Asporogenous Rods; Gram-Positive Bacteria; Gram-Positive Rods; Health and Medicine; Mycobacteria; Mycobacteriaceae; Mycobacterium; Mycobacterium avium; Mycobacterium avium Complex; Risk and Prevention; Surgical Procedures EN Actinobacteria Actinomycetales Atypical Mycobacteria Bronchoscopy Diagnostics and Screening Gram-Positive Asporogenous Rods Gram-Positive Bacteria Gram-Positive Rods Health and Medicine Mycobacteria Mycobacteriaceae Mycobacterium Mycobacterium avium Mycobacterium avium Complex Risk and Prevention Surgical Procedures 451 451 1 06/26/23 20230630 NES 230630 2023 JUL 2 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Imaging Week -- Fresh data on Mycobacterium avium complex are presented in a new report. Actinobacteria, Actinomycetales, Atypical Mycobacteria, Bronchoscopy, Diagnostics and Screening, Gram-Positive Asporogenous Rods, Gram-Positive Bacteria, Gram-Positive Rods, Health and Medicine, Mycobacteria, Mycobacteriaceae, Mycobacterium, Mycobacterium avium, Risk and Prevention, Surgical Procedures, Mycobacterium avium Complex. [Extracted from the article]

Jacksonville, State:Florida, United States, North and Central America, Biomedicine, Drugs and Therapies, Gram-Positive Bacterial Infections, Health and Medicine, Lung Transplantation, Lung Transplants, Mycobacterium Avium Complex, Organ Transplants, Surgery, Transplant Medicine Keywords: Jacksonville; State:Florida; United States; North and Central America; Biomedicine; Drugs and Therapies; Gram-Positive Bacterial Infections; Health and Medicine; Lung Transplantation; Lung Transplants; Mycobacterium Avium Complex; Organ Transplants; Surgery; Transplant Medicine EN Jacksonville State:Florida United States North and Central America Biomedicine Drugs and Therapies Gram-Positive Bacterial Infections Health and Medicine Lung Transplantation Lung Transplants Mycobacterium Avium Complex Organ Transplants Surgery Transplant Medicine 205 205 1 05/22/23 20230525 NES 230525 2023 MAY 25 (NewsRx) -- By a News Reporter-Staff News Editor at Blood Weekly -- A new study on Gram-Positive Bacterial Infections - Mycobacterium Avium Complex is now available. [Extracted from the article]

Keywords: West Lafayette; State:Indiana; United States; North and Central America; Connective Tissue Cells; Gram-Positive Bacterial Infections; Health and Medicine; Immunology; Macrophages; Menopause; Mononuclear Phagocyte System; Mycobacterium Avium Complex; Myeloid Cells; Phagocytes; Risk and Prevention; Women's Health EN West Lafayette State:Indiana United States North and Central America Connective Tissue Cells Gram-Positive Bacterial Infections Health and Medicine Immunology Macrophages Menopause Mononuclear Phagocyte System Mycobacterium Avium Complex Myeloid Cells Phagocytes Risk and Prevention Women's Health 603 603 1 03/23/23 20230324 NES 230324 2023 MAR 23 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators publish new report on Gram-Positive Bacterial Infections - Mycobacterium Avium Complex. Menopause-associated immune disruption includes increased cytokine and chemokine production, and reduced cytotoxicity and phagocytosis in macrophages. [Extracted from the article]

In an embodiment, about 40 milligram (mg) of clofazimine and about 120 milligram (mg) of rifabutin is provided as three fixed-dose combination drug products, each drug product comprising a fixed 158.3 milligram (mg) dose of clarithromycin, a fixed 13.3 milligram (mg) dose of clofazimine and a fixed 40.0 milligram (mg) dose of rifabutin." The method of claim 9, wherein the about 475 milligram (mg) of clarithromycin, about 40 milligram (mg) of clofazimine and about 120 milligram (mg) of rifabutin is provided as 3 fixed-dose combination drug products, each drug product comprising a fixed 158.3 milligram (mg) dose of clarithromycin, a fixed 13.3 milligram (mg) dose of clofazimine and a fixed 40.0 milligram (mg) dose of rifabutin. [Extracted from the article]

Keywords: Actinobacteria; Actinomycetales; Atypical Mycobacteria; Diagnostics and Screening; Gram-Positive Asporogenous Rods; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Gram-Positive Rods; Health and Medicine; Mycobacteria; Mycobacteriaceae; Mycobacterium; Mycobacterium Avium Complex; Mycobacterium avium; Mycobacterium avium Complex; Pulmonary Disease EN Actinobacteria Actinomycetales Atypical Mycobacteria Diagnostics and Screening Gram-Positive Asporogenous Rods Gram-Positive Bacteria Gram-Positive Bacterial Infections Gram-Positive Rods Health and Medicine Mycobacteria Mycobacteriaceae Mycobacterium Mycobacterium Avium Complex Mycobacterium avium Mycobacterium avium Complex Pulmonary Disease 2023 FEB 10 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on Mycobacterium avium complex is now available. Actinobacteria, Actinomycetales, Atypical Mycobacteria, Diagnostics and Screening, Gram-Positive Asporogenous Rods, Gram-Positive Bacteria, Gram-Positive Rods, Health and Medicine, Mycobacteria, Mycobacteriaceae, Mycobacterium, Mycobacterium Avium Complex, Mycobacterium avium, Pulmonary Disease, Mycobacterium avium Complex, Gram-Positive Bacterial Infections. [Extracted from the article]

Tokyo, Japan, Asia, Actinobacteria, Actinomycetales, Antibiotics, Atypical Mycobacteria, Clarithromycin Therapy, Erythromycin Therapy, Gram-Positive Asporogenous Rods, Gram-Positive Bacteria, Gram-Positive Rods, Health and Medicine, Mycobacteria, Mycobacteriaceae, Mycobacterium, Mycobacterium avium, Pulmonary Disease, Mycobacterium avium Complex, Surgery Keywords: Tokyo; Japan; Asia; Actinobacteria; Actinomycetales; Antibiotics; Atypical Mycobacteria; Clarithromycin Therapy; Erythromycin Therapy; Gram-Positive Asporogenous Rods; Gram-Positive Bacteria; Gram-Positive Rods; Health and Medicine; Mycobacteria; Mycobacteriaceae; Mycobacterium; Mycobacterium avium; Mycobacterium avium Complex; Pulmonary Disease; Surgery EN Tokyo Japan Asia Actinobacteria Actinomycetales Antibiotics Atypical Mycobacteria Clarithromycin Therapy Erythromycin Therapy Gram-Positive Asporogenous Rods Gram-Positive Bacteria Gram-Positive Rods Health and Medicine Mycobacteria Mycobacteriaceae Mycobacterium Mycobacterium avium Mycobacterium avium Complex Pulmonary Disease Surgery 2023 FEB 10 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on Gram-Positive Bacteria - Mycobacterium avium Complex is now available. [Extracted from the article]

The company said, 'In light of positive data received from the ongoing non-clinical program with RHB-204, RedHill plans to initiate pivotal Phase 3 study activities with RHB-204 for the treatment [...]

RedHill plans to initiate pivotal Phase 3 study activities with RHB-204 for the treatment of pulmonary NTM infections in the fourth quarter of 2019, subject to completion of the ongoing [...]

2019 JUN 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Gram-Positive Bacteria - Mycobacteria. According to news [...]

RedHill Biopharma announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a new patent covering RHB-104 for Crohn's disease and RHB-204 for [...]

Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, presented new data from the ongoing phase 3 CONVERT study [...]

Insmed presented new data from the ongoing Phase 3 CONVERT study of ARIKAYCE in patients with refractory Mycobacterium avium complex lung disease, demonstrating that the addition of ARIKAYCE to guideline-based [...]

2019 MAY 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Biotechnology - Liposomes are discussed in a new report. [...]

2019 APR 13 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Gram-Positive Bacteria - Mycobacterium avium have been published. [...]

Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, announced that the US Patent and Trademark Office (USPTO) has [...]

Insmed Incorporated announced that the U.S. Patent and Trademark Office has issued patent No. 10,251,900 for certain uses of ARIKAYCE. The claims of the patent relate in part to methods [...]

Insmed Incorporated, a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, provided an update on the US launch of Arikayce (amikacin [...]

2019 MAR 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Gram-Positive Bacteria - Mycobacterium avium is the subject of [...]

2018 DEC 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Gram-Positive Bacteria - Mycobacterium avium Complex is now [...]

2018 JUL 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Gram-Positive Bacterial Infections - Mycobacterium Avium Complex are discussed [...]

2018 MAY 5 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Gram-Positive Bacteria - Mycobacterium avium Complex are discussed in [...]

2018 MAR 3 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Gram-Positive Bacterial Infections - Mycobacterium Avium Complex. [...]